v3.26.1
Stock-Based Compensation (Tables)
 12 Months Ended
May 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Pre-Tax Compensation Expense and Related Tax Benefits Excluding fully vested and non-forfeitable deferred stock units described under "Director Fees and Director Deferred Compensation Plan" below, pre-tax compensation expense and the related income tax benefit for all types of stock-based programs were as follows for the periods indicated:
(In millions)
May 30, 2026May 31, 2025June 1, 2024
Employee stock purchase program$0.5 $0.5 $0.5 
Stock options 1.5 3.5 7.7 
Restricted stock units17.7 22.6 8.7 
Performance share units6.3 5.2 3.4 
Restricted stock awards— — 0.3 
Total$26.0 $31.8 $20.6 
Tax benefit$6.3 $7.7 $5.0 
Schedule of Fair Value of Employee Stock Options In determining these values, the following weighted-average assumptions were used for the options granted during the fiscal years indicated:
20252024
Valuation MethodBlack-ScholesBlack-Scholes
Risk-free interest rates (1)
 
4.53%
 
3.76% to 3.94%
Expected term of options (2)
 5.3 years 4.9 years
Expected volatility (3)
 
50.33%
 
49.33% to 50.26%
Dividend yield (4)
 
3.13%
 
2.90% to 4.79%
Weighted-average grant-date fair value of stock options:
Granted with exercise prices equal to the fair market value of the stock on the date of grant$8.48$9.61 
Granted with exercise prices greater than the fair market value of the stock on the date of grantN/A$4.94 
(1) Represents term-matched, zero-coupon risk-free rate from the Treasury Constant Maturity yield curve, continuously compounded.
(2) Represents historical settlement data, using midpoint scenario with 1-year grant date filter assumption for outstanding options.
(3) The blended volatility approach was used. 90% term-matched historical volatility from daily stock prices and 10% weighted average implied volatility from the 30 days preceding the grant date for fiscal 2025 and the 90 days preceding the grant date for fiscal 2024.
(4) Represents the quarterly dividend divided by the three-month average stock price as of January 13, 2025, July 14, 2023, and January 12, 2024 for 2025, and 2024, respectively.
Schedule of Stock Option Plan Transactions
The following is a summary of stock option activity during fiscal 2026:
Shares Under OptionWeighted-Average Exercise Prices
Aggregate Intrinsic Value
(in millions)
Weighted-Average Remaining Contractual Term (Years)
Outstanding at May 31, 20254,256,929 $24.19 $— 6.5
     Granted— — 
Exercised(23,453)20.00 
Forfeited or expired(371,605)22.06 
Outstanding at May 30, 20263,861,871 24.42  — 5.3
Exercisable at end of period3,325,611 $25.13 $— 5.0
Schedule of Restricted Stock Unit (RSU) Activity
The following is a summary of restricted stock unit activity during fiscal 2026:
Share
Units
Weighted Average
Grant-Date
Fair Value
Aggregate Intrinsic Value (in millions)Weighted-Average
Remaining Contractual
Term (Years)
Outstanding at May 31, 20251,571,198 $25.22  $26.7  0.7
Granted1,202,060 19.59   
Forfeited(142,564)20.79   
Released(968,092)26.49   
Outstanding at May 30, 20261,662,602 $20.94  $27.4  0.9
Schedule of Performance-based Stock Units (PSU) Activity
The following is a summary of performance stock unit activity during fiscal 2026:
Share
Units		Weighted Average Grant-Date Fair ValueAggregate Intrinsic Value (in millions)Weighted-Average Remaining Contractual Term (Years)
Outstanding at May 31, 2025627,912 $25.29 $10.6  0.9
Granted378,039 18.83  
Forfeited(256,956)23.54  
Released(121,312)20.35 
Outstanding at May 30, 2026627,683 $23.09 $10.2  1.0
Schedule of Director Share Based Compensation
The following amounts and types of Company equity were issued to non-employee directors during the fiscal years indicated:
202620252024
Shares of common stock53,324  48,387  31,379 
Deferred stock units pursuant to the Director Plan16,000 22,532 16,490 
Stock options— 9,905 8,377